Top 10 Articles
Top Article: A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Abstract
Background: Bapineuzumab, a humanized anti-amyloid-beta (A) monoclonal antibody for the potential treatment of Alzheimer disease (AD), was evaluated in a multiple ascending dose, safety, and efficacy study in mild to moderate AD.
Methods: The study enrolled 234 patients, randomly… Continue Reading
Methods: The study enrolled 234 patients, randomly… Continue Reading










The right size for the European Neurology Congress
Nils Erik Gilhus
Not only neurologists but also neurosurgeons, psychiatrists and pediatricians are specialists that work with disorders in the brain and nervous system. Furthermore neuroradiologists, neurophysiologists and neuropathologists are professionals in the field, as are psychologists, speech therapists, physiotherapists… 